Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs (Q36985913)

17 August 2017

1 reference

title

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs (English)

1 reference

17 August 2017

Andras G Lacko

1

1 reference

17 August 2017

Maya Nair

series ordinal

2

1 reference

17 August 2017

Laszlo Prokai

series ordinal

3

1 reference

17 August 2017

Walter J McConathy

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Drug Delivery

17 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

665-675

1 reference

The rise and rise of drug delivery

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Drug penetration in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Engineered nanoparticles as precise drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Emerging drugs to replace current leaders in first-line therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

The physiology of lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

HDL: the metabolism, function, and therapeutic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Reconstituted low density lipoprotein: A vehicle for the delivery of hydrophobic fluorescent probes to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Evidence for a potential role for HDL as an important source of cholesterol in human adrenocortical tumors via the CLA-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: studies in human leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Inefficient internalization of receptor-bound low density lipoprotein in human carcinoma A-431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Circumvention of multidrug resistance and reduction of cardiotoxicity of doxorubicin in vivo by coupling it with low density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

The role of lipoproteins in the delivery of tumour-targeting photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

MR and fluorescent imaging of low-density lipoprotein receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Safety and Utilization of Blood Components as Therapeutic Delivery Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Physicochemical properties of microemulsion analogues of low density lipoprotein containing amphiphatic apoprotein B receptor sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Reassembly of low-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Serum lipid alterations in acute lymphoblastic leukemia of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Characterization of CLA-1, a Human Homologue of Rodent Scavenger Receptor BI, as a Receptor for High Density Lipoprotein and Apoptotic Thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Getting a handle on "good" cholesterol with the high-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Scavenger receptor class B, type I on non-malignant and malignant human epithelial cells mediates cholesteryl ester-uptake from high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Trophoblast-like human choriocarcinoma cells serve as a suitable in vitro model for selective cholesteryl ester uptake from high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

HDL as a target in the treatment of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

A New Atom-Additive Method for Calculating Partition Coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Progress in the development of alternative pharmaceutical formulations of taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Paclitaxel and its formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Pharmacokinetics of paclitaxel-containing liposomes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Synthesis and bioactivity of 2,4-diacyl analogues of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Tumor specific novel taxoid-monoclonal antibody conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase I study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Recent developments and patenting of lipoprotein based formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

Low density lipoprotein-receptor activity is lost in vivo in malignantly transformed renal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.665

21 January 2018

Identifiers

DOI

10.1517/17425247.4.6.665

1 reference

17 August 2017

1 reference